Cue Biopharma Inc (CUE)
1.63
+0.04
(+2.52%)
USD |
NASDAQ |
May 31, 16:00
1.62
-0.01
(-0.61%)
After-Hours: 20:00
Cue Biopharma Price to Book Value: 2.640 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 2.640 |
| May 30, 2024 | 2.575 |
| May 29, 2024 | 2.559 |
| May 28, 2024 | 2.623 |
| May 24, 2024 | 2.632 |
| May 23, 2024 | 2.818 |
| May 22, 2024 | 3.093 |
| May 21, 2024 | 3.053 |
| May 20, 2024 | 3.028 |
| May 17, 2024 | 2.769 |
| May 16, 2024 | 2.818 |
| May 15, 2024 | 2.656 |
| May 14, 2024 | 2.510 |
| May 13, 2024 | 2.672 |
| May 10, 2024 | 2.818 |
| May 09, 2024 | 3.101 |
| May 08, 2024 | 3.093 |
| May 07, 2024 | 3.530 |
| May 06, 2024 | 3.368 |
| May 03, 2024 | 3.449 |
| May 02, 2024 | 3.044 |
| May 01, 2024 | 3.085 |
| April 30, 2024 | 3.077 |
| April 29, 2024 | 2.300 |
| April 26, 2024 | 2.210 |
| Date | Value |
|---|---|
| April 25, 2024 | 2.283 |
| April 24, 2024 | 2.300 |
| April 23, 2024 | 2.429 |
| April 22, 2024 | 2.542 |
| April 19, 2024 | 2.526 |
| April 18, 2024 | 2.559 |
| April 17, 2024 | 2.640 |
| April 16, 2024 | 2.421 |
| April 15, 2024 | 2.583 |
| April 12, 2024 | 2.834 |
| April 11, 2024 | 2.850 |
| April 10, 2024 | 2.874 |
| April 09, 2024 | 3.077 |
| April 08, 2024 | 3.304 |
| April 05, 2024 | 2.996 |
| April 04, 2024 | 2.882 |
| April 03, 2024 | 2.866 |
| April 02, 2024 | 2.947 |
| April 01, 2024 | 3.077 |
| March 31, 2024 | |
| March 28, 2024 | 2.479 |
| March 27, 2024 | 2.414 |
| March 26, 2024 | 2.414 |
| March 25, 2024 | 2.440 |
| March 22, 2024 | 2.419 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.374
Minimum
Sep 27 2022
19.33
Maximum
Jun 02 2020
5.114
Average
4.473
Median
Aug 04 2021
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 18.40 |
| iBio Inc | 0.8255 |
| Theriva Biologics Inc | 0.1377 |
| Oragenics Inc | 8.766 |
Price to Book Value Related Metrics
| PS Ratio | 10.90 |
| Price | 1.63 |
| Earnings Yield | -65.64% |
| Market Cap | 79.29M |